Klaus Dörner; Ursula Plog; Thomas Bock; Peter Brieger; Andreas Heinz; Frank Wendt; Georg Kremer; Michael Schulz Psychiatrie-Verlag GmbH (2018) Saatavuus: Tulossa! Kovakantinen kirja
Michael D. Wendt Protein-Protein Interactions as Drug Targets
Shaomeng Wang , Yujun Zhao , Denzil Bernard , Angelo Aguilar , Sanjeev Kumar Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapeutics
Kurt Deshayes , Jeremy Murray , Domagoj Vucic The Development of Small-Molecule IAP Antagonists for the Treatment of Cancer
John F. Kadow , David R. Langley , Nicholas A. Meanwell , Michael A. Walker , Kap-Sun Yeung , Richard Pracitto Protein-Protein Interaction Targets to Inhibit HIV-1 Infection
Nicholas A. Meanwell , David R. Langley Inhibitors of Protein-Protein Interactions in Paramyxovirus Fusion – a Focus on Respiratory Syncytial Virus
Andrew B. Mahon , Stephen E. Miller , Stephen T. Joy , Paramjit S. Arora Rational Design Strategies for Developing Synthetic Inhibitors of Helical Protein Interfaces
Michael D. Wendt The Discovery of Navitoclax, a Bcl-2 Family Inhibitor